METHOD FOR OBTAINING LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF RECOMBINANT HUMAN ERYTHROPOIETIN STABLE AT ROOM TEMPERATURE
摘要
<p>The present invention relates, in general, to a lyophilized pharmaceutical composition comprising recombinant human erythropoietin, which retains at least 95 % of its biological activity after 24 months at room temperature. The present invention also relates to a method for producing a recombinant human erythropoietin compound, which is stable at room temperature.</p>
